Germline alteration analysis reveals EPHB4 R91H mutation as a key player in multiple primary lung tumors
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgae074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Jing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Jianshe East Road, Erqi District, Zhengz…. Hauptthemen laut MEDLINE: Lung Neoplasms, Germ-Line Mutation, Receptor, EphB4, Adenocarcinoma of Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Medicine Research Center of Respiratory Disease in Henan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Multiple primary lung tumors are garnering attention from clinicians, with adenocarcinoma emerging as the predominant histological type. Because of the heterogeneity and diffuse distribution of lesions in the same patient, the treatment of multiple primary lung adenocarcinoma (MPLA) is a significant challenge. As a kind of variation unaffected by tumor heterogeneity, germline alterations may play a key role in the development of MPLA. Here, whole-exome sequencing of peripheral blood was employed to obtain germline alteration data. Intergroup comparative analyses on rare and deleterious alterations of MPLA, solitary lung adenocarcinoma, and healthy individuals in an MPLA family were performed to clarify the candidate alterations. Whole-exome sequencing and targeted Sanger sequencing were performed in 27 disseminated MPLA patients to detect the mutation site that had been screened. A rare and deleterious germline alteration, EPHB4R91H, was found in all of the patients of an MPLA family and a patient with disseminated MPLA. It was revealed that EPHB4R91H was able to enhance the proliferation, migration, and invasion ability of A549 cells through increased binding affinity to ephrinB2, which in turn activated the EPHB4/ERK/JNK/MAPK pathway. Our findings corroborate that germline alterations are involved in the development of MPLA. And it was found for the first time that the EPHB4R91H mutation promotes the development of MPLA by enhancing its affinity for ephrinB2 and thereby active EPHB4/ERK/JNK/MAPK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Jianshe East Road, Erqi District, Zhengzhou 450052, Henan, PR China.
- Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Jianshe East Road, Erqi District, Zhengzhou 450052, Henan, PR China.
- Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Jianshe East Road, Erqi District, Zhengzhou 450052, Henan, PR China.
- Department of Thoracic Surgery and Lung Transplantation, The First Affiliated Hospital of Zhengzhou University, Jianshe East Road, Erqi District, Zhengzhou 450052, Henan, PR China.
- Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, University Drive, Callaghan NSW 2308, Australia.
- Academy of Medical Sciences and Department of Immunology, College of Basic Medical Sciences, Zhengzhou University, Kexue Road, Gaoxin District, Zhengzhou 450052, Henan, PR China.
ORCID-Profile: Guojun Zhang
Förderung
- Clinical Medicine Research Center of Respiratory Disease in Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Li, Y., Wang, X., Zhou, Z., Li, X., Yue, S., Wang, H., Yang, M., & Zhang, G. (2025). Germline alteration analysis reveals EPHB4 R91H mutation as a key player in multiple primary lung tumors. Carcinogenesis. https://doi.org/10.1093/carcin/bgae074
Vancouver
Li J, Li Y, Wang X, Zhou Z, Li X, Yue S, et al. Germline alteration analysis reveals EPHB4 R91H mutation as a key player in multiple primary lung tumors. Carcinogenesis. 2025. doi:10.1093/carcin/bgae074
BibTeX
@article{Li2025,
author = {Li, Jing and Li, Yanan and Wang, Xinjuan and Zhou, Zhigang and Li, Xiangnan and Yue, Songwei and Wang, Huaqi and Yang, Ming and Zhang, Guojun},
title = {Germline alteration analysis reveals EPHB4 R91H mutation as a key player in multiple primary lung tumors},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgae074}
}
EUVIMED